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r Malcolm V. Brock (Baltimore, Md). The authors present an
legant study using a mouse model to investigate the structural
echanics and the dynamic interactions of the pulmonary and
ronchial circulations during chronic inflammation of the lungs.
lthough the bronchial circulation is known to account for less
han 5% of the blood supply and to provide nourishment to the
entral airways, very little is known about the structure of the
ronchial microcirculation. So little is known, in fact, that there
as not even been a demonstration of the existence of bronchial
irculation in the mouse before this report.
The authors’ mouse model has been well validated in some of
heir previous work and seems to provide a very reliable, repro-
ucible inflammatory response in the lung, with resulting edema
nd atelectasis, and histologically there is a very distinct infiltrate
hat develops. The authors show that the mice clinically become
enerally lethargic, have trouble breathing, and the smooth appear-
nce of their fur is altered. They further show that the functional
onsequence of this is noncompliant, stiff lungs. They then take a
ery innovative approach in using a casting technique, along with n
The Journal of Thoracic3-dimensional SEM, to visualize the actual structural connec-
ions between the bronchial and pulmonary microcirculations. The
esults are very clear, dramatic photographs showing what happens
o these connections anatomically during a chronic inflammatory
esponse.
I have three questions. First, the casting at 4 days does give us
sort of one-shot view of what happens to these connections. Have
ou looked at any other time points?
Dr Ravnic. With regard to the timeline, we actually evaluated
ungs 2, 4, and 6 days after the induction of pulmonary inflamma-
ion. At each of these time points we used histologic examination,
orrosion casting, and ventilator measurements. The peak of in-
ammation consistently occurred at 72 to 96 hours, and this was
aralleled by alterations in pulmonary mechanics, as well as an
ncreased flow via the bronchial circulation, as demonstrated by
he casts.
Dr Brock. Would you tell us a little bit about the functional and
linical implications of some of this work for our patients, and
specially in terms of redefining clinical parameters that we can
se for pressure and flow relationships, for example, during a
ulmonary embolism?
Dr Ravnic. Because the bronchial and pulmonary microcircu-
ations are so interconnected, it is suggested that alterations in the
ulmonary circulation would alter flow and pressure in the bronchial
irculation. For example, in inflammatory cases, such as a pulmonary
mbolism or other types of infection, where the pulmonary circulation
utoregulates itself, to minimize ventilation-perfusion mismatching,
ronchial flow may be augmented to continue to deliver systemic
xygenated blood as well as inflammatory cells. If we could devise
way to probe the bronchial circulation and its pressure and flow
haracteristics under these conditions, we might find a correlation
ith the amount of inflammation taking place in the lung.
Dr Brock. Finally, angiogenesis is known to contribute in
any instances in the sort of pathologic damage and repair situ-
tion that you see during inflammation. Did you investigate or see
ny evidence of neovasculature formation in your model, and what
bout its functional significance?
Dr Ravnic. Although neovascularization is certainly a feasible
daptation during increased perfusion, we have not yet specifically
ooked at angiogenesis. We have only been able to demonstrate
hat this functional increase in perfusion occurs during inflamma-
ion. However, we do plan to investigate the effects of angiogen-
sis in the future, as well as any other structural adaptations that
ight occur in the bronchial circulation.
Dr Stephen G. Swisher (Houston, Tex). Do you know what the
nderlying cause of these interconnections is? Could it be the
lveolar macrophages, and have you looked at any models where
he macrophages are depleted?
Dr Ravnic. We have not looked at any models of macrophage
epletion. As far as other cells involved in inflammation, we have
een studying the role of platelets in altering the structure of the
ystemic microvascular network. We have not yet studied the role
f platelets or microphages in altering the structure of the pulmo-
ary network.
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